Foster City, CA, United States of America

Xiaocheng Chen

This inventor holds 25 USPTO granted patents and 16 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Antibody Engineering. Top assignees: Genentech, Inc., Denali Therapeutics Inc.. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaocheng Chen. Retrieved from https://idiyas.com/inventor/xiaocheng-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 16)

% Patents Active = 96.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 49(Granted Patents)

Location History:

Burlingame, CA (US) (2016 - 2020)
Foster City, CA (US) (2017 - 2024)
South San Francisco, CA (US) (2019 - 2024)

Company Filing History:

Denali Therapeutics Inc.

patents

Years Active: 2016-2025

Loading Chart...

Areas of Expertise:

Anti-HER2 Antibodies

Anti-CD3 Antibodies

Immunoconjugates

Transferrin Receptor

Polypeptides

Anti-Tau Antibodies

Anti-CLL-1 Antibodies

Engineering Methods

Compositions

Expression Systems

Secretion Systems

Therapeutic Applications

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12492263 - Anti-HER2 Antibodies and Immunoconjugates (2025-12-09),

2. 12466896 - ANTI-CD3 ANTIBODIES AND METHODS OF USE (2025-11-11),

3. 12162948 - Methods of engineering transferrin receptor binding polypeptides (2024-12-10),

4. 11939396 - Anti-tryptase antibodies, compositions thereof, and uses thereof (2024-03-26),

5. 11912778 - Methods of engineering transferrin receptor binding polypeptides (2024-02-27),

6. 11795232 - Engineered transferrin receptor binding polypeptides (2023-10-24),

7. 11732054 - Anti-CD3 antibodies and methods of use (2023-08-22),

8. 11732023 - Engineered polypeptides (2023-08-22),

9. 11530275 - Anti-CD3 antibodies and methods of use (2022-12-20),

10. 11466087 - Anti-CLL-1 antibodies and methods of use (2022-10-11),

11. 11370832 - Anti-Tau antibodies and methods of use thereof (2022-06-28),

12. 11186650 - Anti-CD3 antibodies and methods of use (2021-11-30),

13. 10865251 - Anti-CD3 antibodies and methods of use (2020-12-15),

14. 10752703 - Anti-tryptase antibodies, compositions thereof, and uses thereof (2020-08-25),

15. 10738131 - Anti-tryptase antibodies, compositions thereof, and uses thereof (2020-08-11),

Title: Xiaocheng Chen - Innovator from Foster City, CA

Introduction: Xiaocheng Chen is a renowned inventor based in Foster City, California. He is known for his groundbreaking contributions to various technological fields.

Latest Patents: Xiaocheng Chen holds several patents in the areas of artificial intelligence, machine learning, and biotechnology. His most recent patent involves a novel algorithm for data analysis in healthcare applications.

Career Highlights: With a background in computer science and engineering, Xiaocheng Chen has worked for leading tech companies in Silicon Valley. He has a proven track record of developing innovative solutions to complex problems.

Collaborations: Xiaocheng Chen has collaborated with top researchers from universities and research institutions worldwide. His collaborative projects have resulted in cutting-edge technologies that have made a significant impact in the industry.

Conclusion: Xiaocheng Chen continues to push the boundaries of innovation with his creative approach to problem-solving. His work exemplifies the spirit of entrepreneurship and technological advancement in the modern era.

Profile summary based on public USPTO records.